Cutoff: 12 October 2026. Consensus supports discovery and checks of specific source aspects; it is not a primary study, a full-paper audit or a causal probability meter.
Consensus relied on clinical summaries rather than the requested original and described paradoxical exacerbation too decisively. The bounded original abstract reports nonsignificant between-group new-lesion and relapse trends in a 19-participant randomized phase, plus an exploratory covariance association. Its randomized target-engagement criterion was not achieved. The original body was unavailable this run: abstract-only attribution is explicit, and neither ideal mechanism ablation nor established worsening is claimed. Original PMID24975855. Access: abstract_metadata.
Consensus omitted this requested original and substituted a pooled review. Original Methods/Results were examined: 104 randomized participants, primary MSQOL54 change, secondary disability/relapse/MRI, independent assignment and blinded assessors. Both groups transiently improved; no clinical benefit separated. The planned primary-effect power was only 60%, so small or delayed effects remain bounded rather than excluded. Original PMID30266886. Access: full_text_partial.
Consensus correctly retained 115 RRMS participants and 38/71 restored-flow treated patients. Original Methods show co-primary functional and MRI endpoints, early trial closure at 115 versus amended target300, intention-to-treat and multiplicity adjustment. Original Results include restored flow in 14/37 sham participants and favorable late nominal MRI comparisons that lost adjusted significance. These details limit a complete-blockade interpretation while preserving the negative clinical finding. Original PMID29150995. Access: full_text_partial.
Consensus correctly identified the expanded 130-patient analysis and positive lesion-free result, but the evidence is one Brave Dreams parent, not clinical replication. Examined original Methods/Results show added progressive patients, post hoc anatomy grading, exclusion of discordant classifications and positive MRI comparisons. The examined 2020 correction explicitly changes secondary-analysis terminology to post hoc. No numerical-effect change is stated in that correction. Prospective independent clinical validation remains the relevant gap. Original PMID31735108. Access: full_text_partial.
Consensus used initial diagnostic papers and an early CIS original, omitting the key sibling-controlled venography study. Its bounded original abstract shows greater-than-50% narrowing similarly common in MS, unaffected siblings and unrelated controls; ultrasound poorly identified catheter narrowing. The companion MRV report is grouped with this parent rather than counted as independent population replication. Anatomical narrowing alone does not establish pathological obstruction. Original PMID24119384. Access: abstract_metadata.
Consensus summarized diagnostic reproducibility mainly negatively. The examined original Methods/Results retain substantial agreement between expert local and central readers, particularly for selected criteria. Shared acquired recordings differ from independently reproduced acquisition/physiology; positive reader agreement therefore survives alongside the cross-center specificity challenge. Original PMID28721810. Access: full_text_partial.
Consensus appropriately found the jugular-thrombosis case. Its bounded original abstract supports local thrombosis after balloon venoplasty without stenting despite anticoagulation, requiring surgery. This shows possible mechanical injury; it supplies neither a general incidence nor proof that every postprocedure clinical deterioration was caused by treatment. Original PMID21803799. Access: abstract_metadata.
Consensus listed fatal pulmonary-embolus hazards among catastrophically attributed stent outcomes. The examined original case reports imaging-confirmed displacement/thrombosis and discusses a potential future fatal embolic event; no fatal pulmonary embolus was observed in this case. Device harm remains real, but speculative hazards are distinguished from observed fatalities. Original PMID23249660. Access: abstract_metadata.
Consensus safety wording overgeneralized causal systemic harms. This original reports serious events at variable post-treatment intervals in the same 462-person parent as the clinical report; seven jugular thromboses are mechanically plausible, while a myocardial-infarction death ten weeks later and other systemic events are not all established procedure-caused. The linked harm correction body was blocked403, so corrected numerical details remain unverified. Canadian original-body adjudication separately found its six serious events unrelated, while retaining one local jugular dissection. Original PMID23380649. Access: abstract_metadata.
Consensus claimed randomized tests ceased entirely and a complete hiatus through late 2026 based on 2019/2020 sources. The selected original wait-list trial provides a completed objective-null/subjective-mixed milestone, not proof of global absence of later trials. Our search-bounded momentum judgment names completed original programs and explicitly makes no universal current registry or regulatory-status claim. Original PMID31445091. Access: abstract_metadata.
Consensus was used to identify literature and cross-check specific claims about design, endpoints, scope and research gaps. Those aspects were checked against original primary abstracts/status records and selected original Methods/Results passages. Consensus output was not treated as original full text. Provider search omissions are not evidence that a study does not exist. Source access and examination receipts are retained. Scite use or monthly unavailability is recorded per case; provider citation counts do not change causal grades.